Hikal logo

Hikal share news, announcements and annual reports

NSE: HIKALBSE: 524735Pharmaceuticals & BiotechnologySmall Cap

Hikal Limited · Face value ₹2 · Listed Jan 1995 on BSE, Feb 2001 on NSE
Last close ₹204.40up ₹2.30 (1.14%)BSE ₹204.75

Share price at the NSE close on 29 Oct 2026. Previous close ₹202.10.

29 Oct: open ₹202.21, high ₹206.02, low ₹201.61

52-week range of traded prices to 29 Oct 2026
₹146.25Low, 30 Mar 2026₹261.00High, 4 Dec 2025
Market cap
₹2,520 Cr1,090th largest listed
P/E
Lossover the last 12 months
P/B
2.10
Dividend yield
0.29%
ROE
−2.7%
ROE without one-offs
3.4%
ROCE
3.5%
Debt to equity
0.57
Volume, NSE
1,47,46136.8% delivered

Hikal board and management

33 filed, newest first.

  1. Oct 2026

  2. Oct 2025

  3. Apr 2025

  4. Feb 2025

  5. Dec 2024

  6. Nov 2024

  7. Aug 2024

  8. Apr 2024

  9. Mar 2024

  10. Jan 2024

  11. Dec 2023

  12. Sep 2023

  13. Aug 2023

  14. Jul 2022

  15. Dec 2021

  16. May 2021

  17. Feb 2021

  18. Oct 2019

  19. Aug 2019

  20. Feb 2018

  21. Mar 2012

  22. May 2011

  23. Jul 2010

  24. Sep 2008

    • 2 Sep · Management

      (i) Mr. Jai Hiremath, Chairman and Managing Director, has been re-appointed for a period of 5 years commencing July 01, 2008. (ii) Mr. Sameer Hiremath, Whole-time Director, has been re-appointed for a period of 5 years commencing July 01, 2008 and redesignated as Deputy Managing Director. These appointments were approved by the Shareholders in the Annual General Meeting held on August 21, 2008.
  25. Jul 2008

    • 21 Jul · Management

      In the meeting held on July 17, 2008, the Board has appointed Dr. Peter Pollak as an Additional Director w.e.f. July 17, 2008, u/s 260 of the Companies Act, 1956. Further, the Company has informed that Mr. Bimal Kishore Raizada has resigned from the Board of Directors of the Company w.e.f. July 17, 2008. For more details click here.